Quick Hospitalization Linked to Worse Outcomes in COVID-19

Priscilla Lynch

October 08, 2020

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.

Shorter time from symptom onset to hospitalization is associated with more serious disease and higher mortality in patients with COVID-19, suggests research presented at the 2020 ESCMID Conference on Coronavirus Disease (ECCVID).

The study by Annie Wong-Beringer, PharmD, FCCP, and colleagues, University of Southern California School of Pharmacy, Los Angeles, included 252 patients hospitalized due to COVID-19 between March 14 and May 14.

A third (33%) presented within 3 days of symptom onset, while 27% were admitted after 1 week from onset.

Patients presenting within 3 days after symptom onset tended to be older (65 vs 58 years) and were more likely to have hypertension (59% vs 41%) and chronic kidney disease (14% vs 3%) than those admitted after 1 week.

However, the group that presented within 3 days also had fewer symptoms overall such as fever (55% vs 66%), shortness of breath (48% vs 66%), nonproductive cough (40% vs 66%,) and muscle/joint pain (12% vs 26%), but had higher levels of organ failure and a worse overall assessment.

This quicker-presenting group were ultimately more likely to develop acute respiratory distress syndrome (13% vs 6%) and have higher mortality (15% vs 3%) than those presenting at hospital later.

Just over half the patients (55%) received antiviral therapy. Of these, the mortality rate was 23% in the patients who presented within 3 days compared with 5% in those presenting after 1 week.

Among those who did not receive antiviral therapy, mortality was 7% in the quicker-presenting group whereas none died in the group presenting after 7 days.

Expert Commentary

Question: What are the clinical implications of your findings?

Wong-Beringer: "Clinicians should closely follow patients with underlying conditions such as hypertension and chronic kidney disease to ensure medication adherence and optimal disease control; and target these individuals for vaccine prioritization and aggressive management of COVID-19."

Follow the latest COVID-19 figures in your region and around the globe with our interactive COVID-19 map.

ESCMID Conference on Coronavirus Disease (ECCVID) 2020: Abstract 00331. Presented September 23-25, 2020.

This article originally appeared on Univadis, part of the Medscape Professional Network.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....